Latest News

Register Now – ALA/LaRDR Investigator Meeting 2021

The Investigator Meeting co-organised by ALA and LaRDR will be held via zoom at 6:00 – 7:30 pm (AEDT) on Thursday, 28th October 2021.

Please feel free to forward to others who may be interested – all are welcome.

For further information, please don’t hesitate to contact us:

LaRDR on sphpm-lymphoma@monash.edu or ALA on alaadmin@snowdome.org.au

What is LaRDR?

The Lymphoma and Related Diseases Registry (LaRDR) is an Australasian initiative to improve the treatment and outcomes of patients with lymphoma.

The LaRDR is managed by Monash University’s School of Public Health and Preventive Medicine, through the Transfusion Research Unit, which manages a number of other clinical registries for important blood disorders.

The registry will include all new cases of Hodgkin and non-Hodgkin lymphomas at registered hospital sites.   National representative data on diagnosis and treatment will be collected, allowing the LaRDR team to

  • Understand access to care
  • Monitor trends in practice, outcomes and survival
  • Explore variation in factors that influence outcomes including survival and quality of life
  • Benchmark outcomes nationally and internationally
  • Act as a resource for clinical trials

Highlights

icon1-02
0

Estimated number of new cases of Lymphoma diagnosed in Australia in 2019

icon3-02
0

Estimated number of deaths from Lymphoma in Australia in 2019

icon2-02
0%

Chance of surviving Leukaemia in Australia for at least 5 years (2009-2013)

Source: Australian Institute of Health and Welfare. (2019). Cancer in Australia 2019. Canberra: AIHW.

https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2019